Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 10,479 $ 15,636
Accounts receivable and contract asset, net 30,957 16,134
Prepaid expenses and other current assets 3,225 2,504
Total current assets 44,661 34,274
Property and equipment, net 21,988 17,409
Operating lease right-of-use assets 3,240 2,323
Goodwill 22,971 2,816
Intangible assets, net 27,318 13,564
Other assets 2,570 1,918
Total assets 122,748 72,304
Current liabilities    
Accounts payable 1,633 1,587
Deferred revenue, short-term 41,907 26,235
Accrued expenses and other current liabilities 9,965 6,680
Total current liabilities 53,505 34,502
Deferred revenue, long-term 1,813 474
Deferred tax liability, long-term 685  
Other liabilities 5,800 3,513
Total liabilities 61,803 38,489
Commitments and contingencies (Note 18)
Stockholders' equity    
Preferred stock: $0.005 par value; 20,000,000 shares authorized; no shares issued and outstanding as of December 31, 2022 and 2021, respectively
Common stock: $0.005 par value; 500,000,000 shares authorized; 12,243,929 and 11,703,430 shares issued and outstanding as of December 31, 2022 and 2021, respectively 62 58
Additional paid-in capital 153,573 132,780
Accumulated deficit (92,400) (98,785)
Accumulated other comprehensive loss (290) (238)
Total stockholders' equity 60,945 33,815
Total liabilities and stockholders' equity $ 122,748 $ 72,304